M&A / Deals McKesson to acquire Precision Medicine Group for $2.25bn Pharmaceutical TechnologyUS-based healthcare services provider McKesson has agreed to acquire Precision Medicine Group for $2.25bn.Read full story pharminent August 26, 2026 (Last updated: September 1, 2026) Pharmaceutical Technology US-based healthcare services provider McKesson has agreed to acquire Precision Medicine Group for $2.25bn. Read full story Post navigation Previous: FDA Approves J&J’s Imaavy for Warm Autoimmune Hemolytic Anemia, the First Therapy Ever Cleared in the DiseaseNext: Jazz secures FDA approval for Ziihera in advanced HER2+ GEA Related Stories M&A / Deals Lilly adds to immune drug pipeline with $2.9B Merida buyout pharminent August 31, 2026 M&A / Deals Acquisitive Lilly offers $2.88bn for Merida Bio pharminent August 31, 2026 M&A / Deals Metsera backers establish new biotech armed with China-licensed immunology asset pharminent August 26, 2026
